IPRs Provide a Useful Alternative to Litigation for Challenging Key Patents

March 1, 2017

PTAB Institutes IPR filed by Celltrion for Rituximab Patent

February 28, 2017

Celltrion’s Truxima (rituximab) Approved in Europe

February 27, 2017

Celltrion Files IPR Petition on Herceptin® Patent

February 22, 2017

Genentech Sues Amgen Over BPCIA Disclosures for Avastin® (bevacizumab)

February 20, 2017

FDA Accepts BLA from Mylan and Biocon for Pegfilgrastim Biosimilar

February 16, 2017

FDA Provides a Snapshot of the Biosimilar Development Programs

February 8, 2017

Coherus Files Four IPR Petitions on Humira® Patent

February 1, 2017

Hospira Files Two More IPR Petitions on Herceptin® Patents

January 31, 2017

Supreme Court Grants Certiorari in First Biosimilar Case

January 26, 2017